InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Stengone Carmine N., 首席执行官. Insider active across 2 companies, notably Contineum Therapeutics, Inc.. Aggregated, 12 filings have been published. Split: 1 buy · 4 sells. Total volume traded: €109k. History available since 11 September 2024. The latest transaction was disclosed on 8 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stengone Carmine N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,500 股@ US$1.01Class A Common StockSEC:0001628280-26-060962:0
2,500 股@ US$16.4566Class A Common StockSEC:0001628280-26-060962:1
2,500 股@ US$1.010.0004% mcap2.8% 占其流量Class A Common StockSEC:0001628280-26-052031:0
2,500 股@ US$16.01160.0069% mcap43.8% 占其流量Class A Common StockSEC:0001628280-26-052031:1
2,500 股@ US$1.010.0005% mcap4.7% 占其流量Class A Common StockSEC:0001628280-26-047710:0
2,500 股@ US$16.000.0074% mcap75.1% 占其流量Class A Common StockSEC:0001628280-26-047710:1
7,500 股Class A Common StockSEC:0001628280-26-046653:0
2,500 股Class A Common StockSEC:0001628280-26-046653:1
10,000 股Class A Common StockSEC:0001628280-26-046653:2
4,400 股@ US$1.260.0011% mcap50.0% 占其流量Class A Common StockSEC:0001437749-26-005892:0
400 股@ US$1.261.0% 占其流量Class A Common StockSEC:0001437749-26-004126:0
1,250 股@ US$3.68100.0% 占其流量Common StockSEC:0001372514-24-000115:0
标准退出：2024年12月10日 (T+90)
12 条申报中的 12 条
About Stengone Carmine N.
Stengone Carmine N. is Directeur Général at Contineum Therapeutics, Inc., and Director at Kiora Pharmaceuticals INC. He has 10 filings in total, and across the 10 most recent filings we hold, buys amount to EUR 4178 and sells to EUR 69781, between 2024-09-12 and 2026-08-03.
